Cargando…
Melatonin and Abeta, Macular Degeneration and Alzheimers Disease: Same Disease, Different Outcomes?
Aging is the common denominator and the highest risk factor for macular degeneration and Alzheimers Disease (AD). Important pathological hallmarks common to both diseases are the presence of amyloid β (Aβ) in the senile plaques of the AD brain and in the drusen of age-related macular degeneration (A...
Autores principales: | Vladan, Bajic, Panfoli, Isabella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medical Hypothesis, Discovery & Innovation Ophthalmology
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3939747/ https://www.ncbi.nlm.nih.gov/pubmed/24600616 |
Ejemplares similares
-
Beneficial Effect of Antioxidants in Retinopathies: A New Hypothesis
por: Panfoli, Isabella
Publicado: (2012) -
Systemic Administration of Abeta mAb Reduces Retinal Deposition of Abeta and Activated Complement C3 in Age-Related Macular Degeneration Mouse Model
por: Catchpole, Ian, et al.
Publicado: (2013) -
Highly specific and ultrasensitive plasma test detects Abeta(1–42) and Abeta(1–40) in Alzheimer’s disease
por: Thijssen, Elisabeth H., et al.
Publicado: (2021) -
A hypothetical therapeutic effect of light peripheral panretinal photocoagulation in neovascular age-related macular degeneration
por: Mansour, Ahmad M, et al.
Publicado: (2022) -
Is Reticular Macular Disease a Choriocapillaris Perfusion Problem?
por: A. Martillo, Miguel, et al.
Publicado: (2012)